Melqart Asset Management »

Revolution Medicines shares owned by Melqart Asset Management

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Melqart Asset Management from 13F filings

Historical chart of Melqart Asset Management investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Melqart Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Melqart Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $26M 270k 97.25

More positions owned by Melqart Asset Management

Electronic Arts (EA)
PNM Resources (TXNM)
Warner Bros Discovery Com Ser A (WBD)
Cytokinetics Com New (CYTK)
Chart Industries (GTLS)
Clearwater Analytics Hldgs I Cl A (CWAN)
Norfolk Southern (NSC)
Kenvue (KVUE)
NVIDIA Corporation (NVDA)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Sandisk Corp (SNDK)
Global Payments (GPN)
Penumbra (PEN)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)

View all positions for Melqart Asset Management

Top funds holding Revolution Medicines

Vanguard Group
Farallon Capital Management
BlackRock
Henderson Group
Baker Bros. Advisors
FMR
Vanguard Capital Management
Nextech Invest
Vanguard Portfolio Management
Wellington Management Company
Paradigm Biocapital Advisors
Bellevue Group
UBS Group
State Street Corporation
Geode Capital Management

View all funds holding Revolution Medicines